Ghassan Aldurra, MD
Specialist in Hinsdale, Illinois.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 69,608 in Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Ghassan Aldurra, MD reported a CMS MIPS final score of 91.4/100 - above the 83.1 national average - and filed 2,236 Medicare Part D claims in 2023.
- 91.4/100
- MIPS score · +8 vs avg
- 2K
- Part D claims, 2023
- 91%
- generic prescribing
- $1.2K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Ghassan Aldurra, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
91 Top 37% higher than 63% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Ghassan Aldurra, MD sits
This provider among specialist peers
Across the 4,869 specialist providers who report both Medicare Part D prescribing and a MIPS quality score, Ghassan Aldurra, MD writes more Part D claims than 74% of them and scores higher on MIPS quality than 72% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one specialist peer from a representative sample of 60; the gold marker is Ghassan Aldurra, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Ghassan Aldurra, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Illinois
How Specialist compares to other specialties among Illinois providers
Specialist ranks #38 among Illinois's specialties (0.6% of in-state providers)
Each bar is a specialty's share of the Illinois provider total, by primary NUCC taxonomy. The highlighted bar is Specialist; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Ghassan Aldurra, MD's 2023 MIPS final score plotted against the Specialist national average
- MIPS Final Score
- 91.4/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Specialist) - 91.4/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Specialist US NPIs
91.4/100 MIPS final score - 8.3 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Specialist. Quality dim: 82.7.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Ghassan Aldurra, MD appears in the CMS NPPES registry as a Specialist provider holding MD credentials at 12 SALT CREEK LN, Hinsdale, IL, 60521, with a listed phone of (630) 789-7800. NPI 1699781310 was issued on 08/01/2006.
Medicare Part D records for calendar year 2023 show 2,236 prescription claims written by this provider, covering 175 Medicare beneficiaries and totaling roughly $387K in drug spend, split 9% brand-name and 91% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.4/100 for the 2023 performance year (Quality 82.7), compared with the national average of 83.1.
Specialist is a high-volume specialty nationwide, with 69,608 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1699781310 |
|---|---|
| Specialty | Specialist |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 08/01/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Ghassan Aldurra, MD's current license status, disciplinary history, and board certifications with the Illinois Department of Financial and Professional Regulation in Illinois before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1699781310 is the unique 10-digit identifier CMS uses to link Aldurra across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Ghassan Aldurra, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ghassan Aldurra, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.2K
Largest payer
Alkermes, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Illinois IDFPR 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 - they are NOT specific to Ghassan Aldurra, MD. To verify Ghassan Aldurra, MD's current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
9% brand-name claims vs 91% generic, on 2,236 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,490
- Total Day Supply
- 104,162
- Brand vs Generic
- 9% brand / 91% generic
- Brand Drug Cost
- $314K
- Generic Drug Cost
- $73K
Patient Demographics
- Average Patient Age
- 70.2 years
- Avg HCC Risk Score
- 1.62
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 43, 65-74: 71, 75-84: 35, 85+: 26
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Ghassan Aldurra, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Aripiprazole
Aripiprazole
242 claims
- Clonazepam
Clonazepam
217 claims
- Escitalopram Oxalate
Escitalopram Oxalate
141 claims
- Quetiapine Fumarate
Quetiapine Fumarate
104 claims
- Venlafaxine Hcl Er
Venlafaxine Hcl Er
97 claims
- Olanzapine 72
Olanzapine
72 claims
- Alprazolam 69
Alprazolam
69 claims
- Mirtazapine 69
Mirtazapine
69 claims
| Drug | Claims |
|---|---|
| Aripiprazole | 242 |
| Clonazepam | 217 |
| Escitalopram Oxalate | 141 |
| Quetiapine Fumarate | 104 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 97 |
| Olanzapine | 72 |
| Alprazolam | 69 |
| Mirtazapine | 69 |
| Duloxetine Hcl | 68 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 67 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Specialist Overview
How Ghassan Aldurra, MD fits within the Specialist landscape nationally.
Ghassan Aldurra, MD's 2,236 claims are above the specialty average of 1,474.
Nearby Specialist Providers in Illinois
Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as Aldurra.
Compare Specialist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Illinois medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Specialist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Illinois
Frequently Asked Questions
What is Ghassan Aldurra, MD's specialty? ▼
How much does Ghassan Aldurra, MD prescribe under Medicare Part D? ▼
What is Ghassan Aldurra, MD's Medicare quality score? ▼
Where is Ghassan Aldurra, MD located? ▼
What is Ghassan Aldurra, MD's NPI number? ▼
Does Ghassan Aldurra, MD prescribe more brand-name or generic drugs? ▼
How many Specialist providers are there in the US? ▼
What drugs does Ghassan Aldurra, MD prescribe most often? ▼
Does Ghassan Aldurra, MD accept Medicare? ▼
How can I verify Ghassan Aldurra, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.